Tests for cystic fibrosis

  1. ๐Ÿ“š Citations
  2. ๐Ÿฆ  Taxons (Bacteria) report by studies
  3. ๐Ÿฅฃ Candidates for improving (avoids and takes)
  4. ๐Ÿ”ฎ Bacteria Related Conditions
  5. es-xenogene is located in Spain and is expensive compared to others

Some 16s providers support download of FASTQ (raw data - BIG FILES). These can be processed thru other services (at the moment, Thryve and Biomesight offers free processing). The bacteria is determine by computer algorithms, which differs from lab to lab.

  1. Biomesight and BiomeSightRdp ships worldwide - including the US
  2. Thryve is now Ombre Labs but only ships to the US
  3. CosmosId is available thru NirvanaBiome
  4. Medivere is based in Germany
  5. American Gut
  6. Xenogene is both the most expensive and most detail for rare bacteria. They are based in Spain
  7. uBiome is no longer in business
The Percentage of significant bacteria each test reports on
Name Percentage
BiomeSight 100%
es-xenogene 100%
Thorne 100%
Thryve 100%
FASTQ processed thru both Thryve and BiomeSight 100%
uBiome 85.7%
Medivere 85.7%
CosmosId 71.4%
SequentiaBiotech 71.4%
AmericanGut 42.9%
BiomeSightRdp 42.9%
Nordic Laboratories 28.6%
NutriPATH 28.6%
Diagnostic Solution GI-Map (cfu/gm) 28.6%
GanzImmun Diagnostic A6 (cfu/gm) 28.6%
GI360 Stool (UK) 28.6%
InVitaLab (cfu/gm) 14.3%
Kyber Kompakt (cfu/g) 14.3%
Medivere: Darn Magen Diagnostik (16s Limited) 14.3%
Medivere: Gesundsheitscheck Darm (16s Limited) 14.3%
GanzImmun Diagnostics AG Befundbericht 14.3%
GI EcologiX (Invivo) 14.3%
Verisana (cfu/ml) aka (kbe/ml) 14.3%
Viome (No objective measures) 14.3%
Biovis Microbiome Plus (cfu/g) 14.3%
DayTwo 14.3%
Microba 14.3%

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.